The Frost & Sullivan Excellence in Financial & Risk Management Awards are presented annually to companies that demonstrate outstanding management of current market conditions, besides preparing for the future, above others within their respective industries. This award recognises Pronova BioPharma's excellent product quality and favourable customer opinions, continued strong customer demand for Omacor/Lovaza, innovation supporting next generation omega-3 derived products (through ongoing collaborations in indications such as heart failure, atrial fibrillation and cardiac disease in type II diabetic patients) and sound operational and financial risk management practices.

"An outstanding business model resulting in strong operational performance coupled with excellence in working capital management has been instrumental in enhancing the company's ROCE and ROE," said Shrikanth S, Senior Research Analyst and Team Leader, Business & Financial, Frost & Sullivan. "Pronova BioPharma has a vision to launch new areas of product application as well as new indications for its API. Ongoing collaborations to develop the use of its API as a monotherapy for indications such as atrial fibrillation, heart failure and as part of primary prevention of cardiac disease in type II diabetic patients are being monitored. Moreover, the company is investing in projects and preclinical studies for next generation omega-3 derived products."

Morten Jurs, CEO and President of Pronova BioPharma, said: "This award is a tribute to the increasing global end-user demand for Omacor/Lovaza which has contributed to Pronova BioPharma's continued excellent revenue and EBITDA growth. We strive for operational excellence and our new plant in Kalundborg will significantly enhance our ability to meet strong customer demand, with first commercial shipments anticipated in Q1 2010. With global sales reaching blockbuster level in Q2 2009, with a global run-rate in June of approximately USD 1.2 billion, we look forward to the continued uptake of this important product worldwide."

--Ends--

About Frost & Sullivan

Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth.